A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Persistently Active Systemic Lupus Erythematosus Despite Moderate Dose Corticosteroids
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Sponsors Mallinckrodt Group
- 22 Sep 2017 Planned End Date changed from 1 Jun 2019 to 1 Apr 2019.
- 22 Sep 2017 Planned primary completion date changed from 1 Feb 2019 to 1 Apr 2019.
- 08 Nov 2016 New trial record